Clinical trial
Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting…
NCT00419185 · University of Luebeck, Other · Completed
Key facts
| NCT number | NCT00419185 |
|---|---|
| Title | Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery |
| Official title | Internal Limiting Membrane (ILM)- Peeling With Indocyanine Green or Trypan Blue in Macular Hole Surgery: A Prospective Randomized Trial |
| Lead sponsor | University of Luebeck, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Idiopathic Macular Hole |
| Intervention type | Procedure |
| Interventions | Delamination of the Internal limiting membrane |
| Enrollment | 40 |
| Start date | Apr 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Jan 8, 2007 |
| Last update posted | Jan 8, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: